What are the types of insulin?

Three measures describe the shape that separates insulins: how quickly the effect starts, how pronounced its strongest moment is, and how wide a time span it covers in total. Put the three together and a curve appears. Two separate families’ curves fall very far apart; the distinction is born there.

The difference comes from the molecule itself. Insulin doesn’t sit alone in the vial; it gathers in clusters of six around zinc. Once under the skin, the cluster must first split into single molecules to mix into the blood. The faster that split, the earlier the effect starts. In rapid-acting analogs a few of the molecule’s building blocks differ, so the cluster sits looser and scatters fast.

With long-acting insulins the aim is the opposite. Some stay clear in the vial but leave a fine deposit once under the skin, dissolving from there little by little. Others latch onto a carrier protein in the blood and linger in circulation. In intermediate-acting insulin a protein called protamine does the same slowing work. The result is a long, low curve with a flattened peak.

Setting the families side by side clears the picture.

The table’s five families cover the forms given under the skin. The powder form drawn into the lungs isn’t read by the same measures; its route runs through the lungs, not the skin.

The table’s roles gather under two headings: background insulin and mealtime insulin. The real question is this: why can’t one curve cover both roles? The body’s own output has two layers too. A low background runs all day and doesn’t stop even in sleep; after a meal, a wave rises and falls fast. Insulins at different speeds exist to imitate these two layers separately.

Still, the family name is a rough category. Some long-acting analogs hold nearly a straight line; some spread wide enough to clear a full day comfortably. Among the rapid-acting ones there are small speed differences too. Two products written on the same row don’t overlap exactly.

Appearance gives a rough clue too. The liquid in the pen or vial is cloudy in intermediate-acting insulins and most premixes, clear in most rapid- and long-acting ones. Even so, the same product doesn’t trace the same curve in everyone. Absorption speed varies noticeably from person to person, and that difference stands out most in human insulin.